Sickle cell disease is a genetic disorder caused by mutations in the beta globin gene, leading to faulty hemoglobin protein, called hemoglobin S. Genetic therapies are approaches to treat genetic disorders by adding new DNA or changing existing DNA. Nucleus highlights how researchers are testing ways to use genome editing technologies to treat sickle cell disease.
Visit our process page to see how our award winning animations get created.
1275 Shiloh Road, Suite 3130 Kennesaw, GA 30144 | Toll-free: 800-333-0753 | Phone: 770-805-0460 | Email: Nucleus Medical Media
©2021 Nucleus Medical Media. All rights reserved.